Stay updated with breaking news from Robert Barrow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
-inc-logo.png&w=240&h=240&zc=2){kind=logo}
Mind Medicine (MindMed) (NASDAQ:MNMD – Get Rating) will be announcing its earnings results after the market closes on Thursday, May 4th. Analysts expect the company to announce earnings of ($0.41) per share for the quarter. Mind Medicine (MindMed) (NASDAQ:MNMD – Get Rating) last released its earnings results on Thursday, March 9th. The company reported ($0.27) […]
Presents Highly Qualified Slate of Director Nominees, Including Five Incumbent Board Members and New Independent Candidate David W. GryskaHighlights Significant Positive Momentum to Advance R&D Pipeline and Enhance Shareholder ValueDiscloses FCM MM HOLDINGS’ Intent to Take Control of the Board Through Nomination of...
Presents Highly Qualified Slate of Director Nominees, Including Five Incumbent Board Members and New Independent Candidate David W. Gryska Highlights Significant Positive Momentum to Advance... | June 19, 2023
Mind Medicine (MindMed) (NASDAQ:MNMD – Get Rating)‘s stock had its “outperform” rating reaffirmed by stock analysts at Oppenheimer in a research report issued to clients and investors on Friday, Benzinga reports. They currently have a $22.00 target price on the stock. Several other equities analysts also recently commented on MNMD. UBS Group started coverage on […]
Mind Medicine (MindMed) (NASDAQ:MNMD – Get Rating)‘s stock had its “buy” rating reiterated by investment analysts at EF Hutton Acquisition Co. I in a note issued to investors on Friday, Benzinga reports. They presently have a $21.00 price target on the stock. EF Hutton Acquisition Co. I’s price target indicates a potential upside of 498.29% […]